Cargando…
Beta cells : functions, pathology, and research /
And Conclusion Acknowledgments ; References; Antagonizing the Endocannabinoid Pathway Prevents the Development of Diabetes and Ý Cell Dysfunction in Zucker Diabetic Fatty Rats ; Abstract ; Methods ; Results ; Introduction ; Materials and Methods ; I. Drugs and Reagents ; II. Animals ; III. Treatmen...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
New York :
Nova Biomedical Books,
©2011.
|
| Colección: | Cell biology research progress.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | EBSCO_ocn836864219 | ||
| 003 | OCoLC | ||
| 005 | 20231017213018.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 130408s2011 nyua ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e pn |c N$T |d YDXCP |d OCLCF |d OCLCQ |d AGLDB |d ICA |d U3W |d D6H |d OCLCQ |d VTS |d COCUF |d INT |d AU@ |d OCLCQ |d STF |d OCLCQ |d M8D |d OCLCQ |d K6U |d OCLCQ |d OCLCO |d SNK |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO | ||
| 020 | |a 9781617613722 |q (electronic bk.) | ||
| 020 | |a 161761372X |q (electronic bk.) | ||
| 020 | |z 9781617612121 | ||
| 020 | |z 161761212X | ||
| 029 | 1 | |a DEBBG |b BV043961456 | |
| 029 | 1 | |a DEBSZ |b 481300554 | |
| 035 | |a (OCoLC)836864219 | ||
| 050 | 4 | |a QP188.P26 |b B48 2011eb | |
| 072 | 7 | |a MED |x 060000 |2 bisacsh | |
| 082 | 0 | 4 | |a 612.3/4 |2 22 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Beta cells : |b functions, pathology, and research / |c Sarah E. Gallagher, editor. |
| 260 | |a New York : |b Nova Biomedical Books, |c ©2011. | ||
| 300 | |a 1 online resource (xi, 176 pages) : |b illustrations (some color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Cell biology research progress | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a BETA CELLS: FUNCTIONS, PATHOLOGY AND RESEARCH ; BETA CELLS: FUNCTIONS, PATHOLOGY AND RESEARCH ; Contents ; Preface ; Stress and Pancreatic Ý Cell Function: Role of Glucocortoids, Exercise and Glucolipotoxicity; Abstract ; Introduction Ý Cell Adaptation Ý Cell Mass in Obesity ; Life Cycle of the Ý Cell ; Glucocorticoids and Ý Cell Function ; Direct Effects of Glucocorticoids on Ý Cells ; Indirect Effects of Glucocorticoids on Ý Cell Function ; Role of GRs on Ý Cell Survival and Replication ; Intermittent Stress and Ý Cell Function ; Exercise Intervention on Ý Cell Function. | |
| 505 | 8 | |a Exercise Causes Pancreatic Regeneration in Partial Pancreatectomy Models Disposition Index on Ý Cell Function ; Age and Exercise on Ý Cell Function; Glucolipotoxicity on Ý Cell Function ; Glucotoxicity; Lipotoxicity ; Short Term Effects of FFAs ; Long Term Effects of FFAs ; FFAs and ER Stress ; Conclusion ; References ; The Synergistic Effect of Ý Cell Replacement and Immunotherapy on the Treatment of Type 1 Diabetes ; Abstract ; Introduction Ý-Cell Replacement ; Patient-Specific ß-Cells ; 1. Autologous adult stem cell-derived ß-cells ; 2. Induced pluripotent stem cells. | |
| 505 | 8 | |a 3. Transdifferentiation-induced Ý-like cells Embryonic Stem Cell-Derived ß-Cells ; Islet Transplantation; Pancreas Transplantation ; Immunotherapy ; Immunopathology of T1D ; Treg-Based Immunotherapy ; 1. Evidence of Treg function in the control of T1D ; 2. Mechanisms of Treg function in T1D ; 3. Therapeutic potential of Tregs on T1D ; Antigen/ Antibody-Based Immunotherapy ; The Potential Synergistic Role of Ý-Cell Replacement and Immunotherapy ; 1. Bi-Directional Actions of Cell-Based Therapy ; 2. Multiple Functions of Immunotherapy ; 3. Temporal and Spatial Actions of Immunotherapy. | |
| 505 | 8 | |a VII. Expression of Results and Statistical Analyses 1. Expression of the results ; 2. Statistical analyses ; Results ; I. Effect of Rimonabant Administration (10 Mg/Kg/D) on Body Weight of ZDF Rats; II. Rimonabant Administration (10 Mg/Kg/D) Prevents the Elevation of Blood Glucose Levels of ZDF Rats ; III. Rimonabant Administration (10 Mg/Kg/D) Reduces the Decline of Insulinemia of ZDF Rats ; IV. Rimonabant Administration (10 Mg/Kg/D) Reduces Cell Dysfunction in ZDF Rats; 1. Insulin secretion during static incubation of islets isolated from ZDF rats treated for 2 weeks. | |
| 520 | |a And Conclusion Acknowledgments ; References; Antagonizing the Endocannabinoid Pathway Prevents the Development of Diabetes and Ý Cell Dysfunction in Zucker Diabetic Fatty Rats ; Abstract ; Methods ; Results ; Introduction ; Materials and Methods ; I. Drugs and Reagents ; II. Animals ; III. Treatment and Follow-up ; IV. Islet Isolation ; V. Glucose-Stimulated Insulin Secretion (GSIS) Assessment by Static Incubation of Isolated ZDF Rat Islets; VI. Glucose-Stimulated Insulin Secretion (GSIS) Assessment by Perifusion of Isolated ZDF Rat Islets. | ||
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 650 | 0 | |a Pancreatic beta cells. | |
| 650 | 0 | |a Diabetes. | |
| 650 | 2 | |a Islets of Langerhans | |
| 650 | 6 | |a Cellules bêta des îlots de Langerhans. | |
| 650 | 7 | |a MEDICAL |x Nutrition. |2 bisacsh | |
| 650 | 7 | |a Diabetes |2 fast | |
| 650 | 7 | |a Pancreatic beta cells |2 fast | |
| 700 | 1 | |a Gallagher, Sarah E. | |
| 776 | 0 | 8 | |i Print version: |t Beta cells. |d New York : Nova Biomedical Books, ©2011 |z 9781617612121 |w (DLC) 2010027623 |w (OCoLC)649077700 |
| 830 | 0 | |a Cell biology research progress. | |
| 856 | 4 | 0 | |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=540538 |z Texto completo |
| 938 | |a EBSCOhost |b EBSC |n 540538 | ||
| 938 | |a YBP Library Services |b YANK |n 3418648 | ||
| 994 | |a 92 |b IZTAP | ||